Cargando…
Azithromycin, RECOVERY, and the power of large, simple trials
Autor principal: | Berwanger, Otavio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906649/ https://www.ncbi.nlm.nih.gov/pubmed/33545097 http://dx.doi.org/10.1016/S0140-6736(21)00307-X |
Ejemplares similares
-
Fluvoxamine for outpatients with COVID-19: where do we stand?
por: Berwanger, Otavio
Publicado: (2022) -
Azithromycin for severe COVID-19
por: Oldenburg, Catherine E, et al.
Publicado: (2020) -
Aortic arch calcification: A simple but powerful marker of subclinical cardiovascular disease
por: Qazi, Saadia, et al.
Publicado: (2022) -
Azithromycin: can its benefit be ruled out in mild COVID-19?
por: Rodríguez-Molinero, Alejandro
Publicado: (2021) -
Recovery after prolonged ICU treatment in patients with COVID-19
por: Parotto, Matteo, et al.
Publicado: (2021)